title: Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) in Croatia.
abstract: We report on the prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase in 20 at-risk pregnancies (16 salt-wasting and 4 simple virilizing families). We have diagnosed 3 affected fetuses (2 males and 1 female), 3 healthy homozygotes (2 males and 1 female), and 14 healthy heterozygotes (7 females and 7 males). These data were collected over 4 years. In 16 fetuses, the diagnosis was made with measurements of 17-hydroxyprogesterone (17-OHP) and delta-4-androstenedione (delta) in amniotic fluid (AF), human leukocyte antigen (HLA) typing of amniotic cells, as well as karyotypes between the 16th and 18th weeks of gestation. In 4 fetuses, DNA analysis of amniotic cells was also performed. In 3 pregnancies in which affected fetuses were suspected (on the basis of HLA typing and measurements of 17-OHP and delta concentrations in AF), the fetuses were electively aborted between the 17th to 19th weeks of gestation by parental decision. In all aborted fetuses, diagnosis was confirmed with HLA typing, autopsy findings of hyperplastic adrenal glands, and ambiguous genitalia in female fetuses. Postnatal diagnosis was confirmed in healthy fetuses with HLA typing and serum measurements of 17-OHP concentrations, and in 4 of them with DNA analysis. In 3 of the 4 families, DNA analyses revealed the following mutations: in Family 1, the index case mutation was Intron 2, Exon 3/Exon 6, and the fetus was Normal/Exon 6; in Family 2, the index case mutation was Ex1 Int2 Ex3/ Int2, and the fetus was Ex1 Int2 Ex3/Normal; and in Family 3, the index case mutation was Ex8(356)/Ex8(356), and the fetus was Ex8(356)/ Normal. We also report one case of prenatal diagnosis and treatment. Dexamethasone 0.5 mg BID (20 micrograms/kg/d) was given starting at 6th week of gestation. Prenatal diagnosis suggested, but did not prove, that the female fetus was a heterozygote as the fetus lacked the paternal mutation Ex8(318). No mutation was found in the mother. The fetus, the mother, and the affected sib shared a haplotype, further suggesting heterozygosity. The unaffected status was confirmed postnatally.
authors.affiliation: Department of Pediatrics, University Hospital, Zagreb, Croatia.
authors.forename: M
authors.initials: M
authors.lastname: Dumic
authors.forename: L
authors.initials: L
authors.lastname: Brkljacic
authors.forename: V
authors.initials: V
authors.lastname: Plavsic
authors.forename: R
authors.initials: R
authors.lastname: Zunec
authors.forename: J
authors.initials: J
authors.lastname: Ille
authors.forename: R C
authors.initials: RC
authors.lastname: Wilson
authors.forename: I
authors.initials: I
authors.lastname: Kuvacic
authors.forename: A
authors.initials: A
authors.lastname: Kastelan
authors.forename: M I
authors.initials: MI
authors.lastname: New
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000032:analysis; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis* / Q000196:embryology / Q000235:genetics; D015193:Chorionic Villi Sampling; D017523:Croatia; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D010375:Pedigree; D011296:Prenatal Diagnosis; D011863:Radioimmunoassay
chemical_list: D019326:17-alpha-Hydroxyprogesterone